XEXP:CA:TSX-iShares Exponential Technologies Index ETF CAD (CAD)

ETF | Others |

Last Closing

CAD 50.98

Change

+1.19 (+2.39)%

Market Cap

CAD 0.02B

Volume

130.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.21 (+0.61%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.01 (+0.03%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.53 (-2.06%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.15 (+0.40%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.58 (+1.17%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.92 (+3.29%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.19 (+1.72%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.17 (+0.76%)

CAD 2.78B

ETFs Containing XEXP:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.76% 45% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.76% 43% F 35% F
Trailing 12 Months  
Capital Gain 4.68% 51% F 47% F
Dividend Return 0.21% 6% D- 3% F
Total Return 4.89% 40% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.87% 73% C 62% D
Dividend Return 7.91% 72% C 57% F
Total Return 0.04% 6% D- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 7.13% 66% D+ 83% B
Risk Adjusted Return 110.92% 98% N/A 96% N/A
Market Capitalization 0.02B 29% F 13% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.